Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis

NCT01332929 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT01332929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01332929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis
Lead sponsor
Centre Francois Baclesse
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2010
Completion date
July 31, 2013
Enrollment
21 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm to brain